Rancho Biosciences Welcomes Seventh Member to Single-Cell Data Science Consortium
SAN DIEGO, CA / ACCESSWIRE / January 9, 2024 / Rancho Biosciences, the leading Data Science Services company headquartered in...
Day: January 9, 2024
Mazree and Capstone Health Alliance Join Forces to Revolutionize Equipment Value Recovery in Healthcare
Mazree, a cutting-edge provider of medical equipment disposition services, has announced a strategic partnership with Capstone Health Alliance, one of...
CardioComm Solutions Appoints New CFO
Toronto, Ontario--(Newsfile Corp. - January 9, 2024) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical...
Paragonix SherpaPak Recognized for Maximizing Access to the Donor Pool in New Clinical Study
The Journal of Lung and Heart Transplantation (JHLT) has published a real-world study indicating a significant reduction in Primary Graft...
Establishment Labs Announces $50 Million Private Placement and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2023
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA) (“Establishment Labs” or the “Company”), a global medical technology company dedicated to...
Sonendo Continues Expanding the Reach of Its GentleWave Procedure; Partners with Dental Purchasing Group
More Clinicians and Patients Will Now Have Access to This Revolutionary Technology for Less Invasive, Patient-Friendly Root Canal TherapyLAGUNA HILLS,...
Endologix Announces that Scott Ward Joins Board of Directors
IRVINE, Calif.--(BUSINESS WIRE)--#endologix--Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment...
Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2023 Net Sales and Reaffirms 2024 Revenue Guidance
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the...
Liviniti Announces Noom GLP-1 Companion and Comprehensive Weight Management Solution
Liviniti adopts Noom to support sustainable weight loss and healthier outcomes.Natchitoches, Louisiana--(Newsfile Corp. - January 9, 2024) - Liviniti, a...
Halberd Corp. Signs Significant Revenue Sharing Agreement with Athena GTX
Athena will employ its successful history of securing government contracts, spearheading such initiativesJACKSON CENTER, PA / ACCESSWIRE / January 9,...
Levity Products, Inc Announces New Distribution Agreement with Domrex Pharma, Inc to Expand Market Reach
HUGO, MN / ACCESSWIRE / January 9, 2024 / Levity Products, Inc., an innovative provider of catheter stabilizers, today announced...
NEXGEL Subsidiary, CG Converting and Packaging, Begins 12,000 Square Foot Expansion of Texas Facility to Support the Expected Growth in Product Demand in 2024
LANGHORNE, Pa., Jan. 09, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL), a leading provider of...
SeaStar Medical Issued U.S. Patent with Broad Claims Covering Use of the Selective Cytopheretic Device for Multiple Clinical Indications
DENVER, Jan. 09, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions...
SELLAS Life Sciences Receives FDA Fast Track Designation for SLS009 for Treatment of Relapsed/Refractory Acute Myeloid Leukemia and Provides Updated Data for Phase 2a Study of SLS009 in Relapsed/Refractory Acute Myeloid Leukemia Patients
- Phase 2a Enrollment Completed in 45 mg Safety Cohort: Median Overall Survival (OS) Not Reached; 89% of Patients Alive...
Dentsply Sirona to Present at J.P. Morgan Healthcare Conference, Provides Update on Anticipated Full Year 2023 Results
CHARLOTTE, N.C., Jan. 09, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) will present...
Branded Legacy, INC Successfully Closes Acquisition of All In Extracts, LLC
In a Move That Showcases the Power of Cooperation Over Competition, Companies Join Forces to Bring Exciting New Products to...
BioCorRx Appoints Renowned Investment and Capital Markets Executive Louis Lucido as President
ANAHEIM, CA, Jan. 09, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and...
IRADIMED CORPORATION Reports Unaudited Fourth Quarter and 2023 Revenue
Reports preliminary fourth quarter 2023 revenue of $17.5 million WINTER SPRINGS, Fla., Jan. 09, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION...
Ashley Black Interviewed Live from NYSE on Wellness Industry Innovations with FinTech TV
Ashley Black Interview from NYSE - ESG News Ashley Black Interview from NYSE - ESG News INTERVIEW HIGHLIGHTS $170 Million...
eFFECTOR Therapeutics to Host Virtual Investor R&D Day on January 24, 2024
- Summary of development progress for tomivosertib and zotatifin and a preview of anticipated 2024 milestones- - Review of recently...